Drug & Medication Database

Browse 18,617 FDA-approved medications with detailed information about uses, dosage, side effects, and interactions.

Desmopression Acetate

desmopression acetate

OTC

Dosage form: POWDER. Active ingredients: DESMOPRESSIN ACETATE (25 kg/25kg). Category: BULK INGREDIENT.

Desogestrel

desogestrel

OTC

Dosage form: POWDER. Active ingredients: DESOGESTREL (1 kg/kg). Category: BULK INGREDIENT.

Desogestrel And Ethinyl Estradiol

desogestrel and ethinyl estradiol

OTC

Indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Brands: Desogestrel And Ethinyl Estradiol

Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol

desogestrel and ethinyl estradiol and ethinyl estradiol

OTC

DESCRIPTION VIORELE ® (desogestrel and ethinyl estradiol tablets, USP and ethinyl estradiol tablets, USP) provides an oral contraceptive regimen of 21 white to off-white, round tablets each containing 0.15 mg desogestrel, USP (13-ethyl-11- methylene-18,19-dinor-17 alpha-pregn- 4-en- 20-yn-17-ol), 0.02 mg ethinyl estradiol, USP (19-nor-17 alpha-pregna-1,3,5 (10)-trien-20-yne-3,17-diol), and inactive ingredients which include vitamin E, potato starch, povidone, isopropyl alcohol, colloidal silicon

Brands: Viorele

Desogestrel/ethinyl Estradiol And Ethinyl Estradiol

desogestrel/ethinyl estradiol and ethinyl estradiol

OTC

DESCRIPTION Pimtrea TM (Desogestrel and Ethinyl Estradiol tablets, USP and Ethinyl Estradiol tablets, USP) provide an oral contraceptive regimen of 21 dark blue tablets each containing 0.15 mg desogestrel (13-ethyl­-11- methylene-18,19-dinor-17 alpha-pregn- 4-en- 20-yn-17-ol), 0.02 mg ethinyl estradiol (19-nor­- 17 alpha-pregna-1,3,5 (10)-trien-20-yne-3,17-diol), and inactive ingredients which include: titanium dioxide, macrogol/PEG 400 NF, hydroxypropylmethylcellulose/hypromellose, FD&C Red No.

Brands: Pimtrea

Desonide

desonide

Corticosteroid [EPC]OTC

Desonide lotion is a low to medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

Brands: Desonide

Desonide 0.05%

desonide 0.05%

Corticosteroid [EPC]OTC

DESCRIPTION SECTION description

Brands: Tridesilon Cream

Desonide Micronized

desonide micronized

OTC

Dosage form: POWDER. Active ingredients: DESONIDE (100 kg/100kg). Category: BULK INGREDIENT.

Desonide Ointment, 0.05%

desonide ointment, 0.05%

Corticosteroid [EPC]OTC

DESCRIPTION Desonide Ointment, 0.05% contains desonide (Pregna-1,4-diene-3,20-dione,11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-,(11ß,16α)) a synthetic corticosteroid for topical dermatologic use. The corticosteroids constitute a class of primary synthetic steroids used topically as anti-inflammatory and antipruritic agents. Chemically, desonide, the active ingredient in Desonide Ointment, 0.05% is C 24 H 32 O 6 .

Brands: Desonide Ointment, 0.05%

Desoximetasone

desoximetasone

Corticosteroid [EPC]OTC

Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Brands: Desoximetasone

Desoximetasone Micronized

desoximetasone micronized

OTC

Dosage form: POWDER. Active ingredients: DESOXIMETASONE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

Desoxycholic Acid

desoxycholic acid

OTC

Dosage form: POWDER. Active ingredients: DEOXYCHOLIC ACID (1 kg/kg). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.

Desoxycorticosterone Acetate

desoxycorticosterone acetate

OTC

Manufactured by NOVARTIS. Dosage form: PELLET. Route: IMPLANTATION. Active ingredients: DESOXYCORTICOSTERONE ACETATE (125MG). Application: NDA005151.

Desoxycorticosterone Pivalate

desoxycorticosterone pivalate

OTC

Dosage form: POWDER. Active ingredients: DESOXYCORTICOSTERONE PIVALATE (1 kg/kg). Category: BULK INGREDIENT.

Desoxyribonuclease

desoxyribonuclease

OTC

Manufactured by PARKE DAVIS. Dosage form: OINTMENT. Route: TOPICAL. Active ingredients: CHLORAMPHENICOL (10MG/GM); DESOXYRIBONUCLEASE (666 UNITS/GM); FIBRINOLYSIN (1 UNITS/GM). Application: BLA050294.

Desvenlafaxine

desvenlafaxine

OTC

Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD).

Brands: Desvenlafaxine

Desvenlafaxine Er

desvenlafaxine er

OTC

Desvenlafaxine is an extended-release tablet for oral administration that contains desvenlafaxine succinate, a structurally novel SNRI for the treatment of MDD. Desvenlafaxine (O-desmethylvenlafaxine) is the major active metabolite of the antidepressant venlafaxine, a medication used to treat major depressive disorder.

Brands: Desvenlafaxine Er

Desvenlafaxine Fumarate

desvenlafaxine fumarate

OTC

Manufactured by TEVA PHARMS USA. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: DESVENLAFAXINE FUMARATE (EQ 100MG BASE). Application: NDA205208.

Desvenlafaxine Fumarate Monohydrate

desvenlafaxine fumarate monohydrate

OTC

Dosage form: POWDER. Active ingredients: DESVENLAFAXINE FUMARATE MONOHYDRATE (1 kg/kg). Category: BULK INGREDIENT.

Desvenlafaxine Succinate

desvenlafaxine succinate

OTC

Desvenlafaxine extended-release tablet is indicated for the treatment of adults with major depressive disorder (MDD).

Brands: Desvenlafaxine Succinate

Desvenlafaxine Succinate Monohydrate

desvenlafaxine succinate monohydrate

OTC

Dosage form: POWDER. Active ingredients: DESVENLAFAXINE SUCCINATE (1 kg/kg). Category: BULK INGREDIENT.

Detomidine Hydrochloride

detomidine hydrochloride

OTC

Dosage form: POWDER. Active ingredients: DETOMIDINE HYDROCHLORIDE (1 g/g). Category: BULK INGREDIENT.

Detoxifying

detoxifying

OTC

Sweep Helps in the detoxification of the body

Brands: Sweep

Deucravacitinib

deucravacitinib

Tyrosine Kinase 2 Inhibitor [EPC]OTC

11 DESCRIPTION Deucravacitinib is a tyrosine kinase 2 (TYK2) inhibitor and is described chemically as: 6-(cyclopropanecarbonylamido)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide. The molecular formula is C 20 H 19 D 3 N 8 O 3 and the molecular weight of the free base is 425.47. Deucravacitinib has the structural formula: Deucravacitinib is a white to yellow powder. The solubility of deucravacitinib is pH dependent.

Brands: Sotyktu

Deucravacitinib Premix

deucravacitinib premix

OTC

Dosage form: POWDER. Active ingredients: DEUCRAVACITINIB (1 kg/kg). Category: BULK INGREDIENT.

Deuruxolitinib Phosphate

deuruxolitinib phosphate

OTC

11 DESCRIPTION LEQSELVI (deuruxolitinib) tablets contain the phosphate salt of deuruxolitinib, a Janus kinase (JAK) inhibitor, for oral administration. Deuruxolitinib phosphate is a white to off-white crystalline solid with the chemical name 1 H -Pyrazole-1-propanenitrile, β-(cyclopentyl-2,2,3,3,4,4,5,5- d 8 )-4-(7 H -pyrrolo[2,3- d ]pyrimidin-4-yl)-, (β R )-, phosphate (1:1). Deuruxolitinib has high aqueous solubility at low pH.

Brands: Leqselvi

Deutetrabenazine

deutetrabenazine

OTC

11 DESCRIPTION AUSTEDO XR extended-release tablets and AUSTEDO tablets are formulated with deutetrabenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor for oral administration. The molecular weight of deutetrabenazine is 323.46; the pKa is 6.31. Deutetrabenazine is a hexahydro-dimethoxybenzoquinolizine derivative and has the following chemical name: ( RR, SS )-1, 3, 4, 6, 7, 11b-hexahydro-9, 10-di(methoxy-d 3 )-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one.

Brands: Austedo, Austedo, Austedo Xr

Deutetrabenazine Micronized

deutetrabenazine micronized

OTC

Dosage form: POWDER. Active ingredients: DEUTETRABENAZINE (1 kg/kg). Category: BULK INGREDIENT.

Deutivacaftor Spray Dried Dispersion

deutivacaftor spray dried dispersion

OTC

Dosage form: POWDER. Active ingredients: DEUTIVACAFTOR (.8 kg/kg). Category: DRUG FOR FURTHER PROCESSING.

Device - Hand-held Rubber Bulb Nebulizer

device - hand-held rubber bulb nebulizer

OTC

Please consult the purpose section of the OTC bronchodilator drug label approved for use with this device.

Brands: Device - Nebuclear Md Hand-held Rubber Bulb Nebulizer

Medical Disclaimer

This drug database is for informational purposes only. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.